Wonvas-Gold Capsule
Images are for reference. Actual packaging may vary.
Strip of 10 capsules • CapsulePrescription requiredSchedule H
Wonvas-Gold Capsule
Aspirin (75mg) + Rosuvastatin (10mg) + Clopidogrel (75mg)
₹133.00
Strip of 10 capsules • Capsule
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Clopidogrel 75 mg
+2 more active ingredients
How It Works
Clopidogrel irreversibly inhibits the P2Y12 component of ADP receptors on platelets, preventing platelet activation and aggregation.
Aspirin irreversibly inhibits COX-1 and COX-2 enzymes, leading to decreased production of thromboxane A2 and prostaglandins.
Rosuvastatin inhibits HMG-CoA reductase, decreasing cholesterol synthesis in the liver and increasing LDL receptor expression.
Medicine Strength
75 mg
All Active Ingredients
Clopidogrel75 mg
Aspirin75 mg
Rosuvastatin10 mg
Uses & Benefits
Medical applications
Cholesterol
Wonvas-Gold Capsule is a combination pharmaceutical formulation containing Aspirin (75 mg), Rosuvastatin (10 mg), and Clopidogrel (75 mg), designed to provide comprehensive cardiovascular protection. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase-1 (COX-1), thereby reducing thromboxane A2 synthesis and preventing platelet aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) levels, contributing to the stabilization of atherosclerotic plaques and reduction of cardiovascular risk.
Read full descriptionShow less
Clopidogrel, another antiplatelet agent, selectively inhibits the ADP P2Y12 receptor on platelet surfaces, further preventing platelet activation and aggregation. The synergistic action of these three agents makes Wonvas-Gold Capsule suitable for secondary prevention of atherosclerotic cardiovascular events, including myocardial infarction, stroke, and peripheral arterial disease, particularly in patients with established coronary artery disease or high cardiovascular risk profiles.
This combination therapy should be administered under strict medical supervision due to potential risks such as bleeding complications and hepatic or renal impairment. Regular monitoring of lipid profiles, liver function tests, and complete blood counts is recommended to ensure therapeutic efficacy and safety. Wonvas-Gold Capsule is contraindicated in patients with active bleeding, hypersensitivity to any component, or severe hepatic dysfunction.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Wonvas-Gold Capsule
